|
Because this drug wasn't created in America, and the medical trials weren't done in America. That's the short answer.
Selective Serotonin Reuptake Inhibitors are not drugs to be taken lightly. They alter the chemistry of the brain. For a person suffering from depression, this can be a helpful change so they can have a better quality of life. In everyone else, it's changing the chemistry of your brain to have better sex. While that may improve the quality of life, it's the FDA's job to be sure that the risks do not outweigh the benefits.
Also, just because a drug is approved somewhere else in the world, doesn't mean it will fit the mold set by the FDA- so there's never any point in saying "well it's ok over there...". This has nothing to do with being better than anyone, it has to do with strict quality and safety control. Britain's is very good as well, in my understanding, but all the British medical trials in the world won't force the hand of the FDA. They need to do their own, to be as sure as they can be that what they approve is safe for use.
|